Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.
about
Macrophage and Innate Lymphoid Cell Interplay in the Genesis of FibrosisInterleukin-1 Family Cytokines in Liver DiseasesPathogenesis of biliary atresia: defining biology to understand clinical phenotypesCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor MicroenvironmentPlatelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.Innate immunity is a key factor for the resolution of inflammation in asthmaInterleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and FibrosisType II cytokines impair host defense against an intracellular fungal pathogen by amplifying macrophage generation of IL-33.IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanismIL-33 activates tumor stroma to promote intestinal polyposis.Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunologyEnhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma.Functional and structural features of cholangiocytes in health and disease.Cell death and cell death responses in liver disease: mechanisms and clinical relevancePrimary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in CholangiocarcinomaTherapeutic targets for cholestatic liver injuryEmerging concepts and future challenges in innate lymphoid cell biologyThe Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Immune cells in liver regeneration.Innate lymphoid cells involve in tumorigenesis.Interleukin-8: A critical chemokine in biliary atresia.Pivotal roles of ILCs in hepatic diseases.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.Recent advancement of molecular mechanisms of liver fibrosis.The potential role of IL-33/ST2 signaling in fibrotic diseases.Group 2 innate lymphoid cells in disease.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.Helminth infection-induced malignancy.Interleukin-33 in health and disease.Emerging concepts in biliary repair and fibrosis.IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection.Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis.Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.Dual roles of yes-associated protein (YAP) in colorectal cancer.
P2860
Q26774652-39F982F2-CF6C-4D6D-BAAF-70D42F818691Q26778553-543A757B-4DB4-4761-BB29-D29C38075A9FQ27006535-67387DAC-A390-45B9-80E5-AA0CEBDA01B3Q28077126-1F58CA1C-58F4-42A2-BD11-D323009D9856Q34044638-A8FE8E32-D974-422F-8922-97C22213A0C7Q34465047-0313BA3B-9610-497C-9190-3DD3AD809A0EQ34534282-3EF9FA8C-3180-44F2-AF5D-7BD8F5959D52Q35079476-B114174F-A58C-40C9-991B-BDB66B7EED61Q35528356-8549E6AB-5B4E-4181-A7EE-4DCBB9A4D87DQ35616286-CBF450B3-0371-4E8C-AA3A-CA1726146138Q35638915-588B71F2-487D-4816-ACB3-E70D591B762EQ35740929-D741F49F-0923-4EB6-8215-3EB960EA0421Q35933236-DB232382-B235-4CD7-AA32-831EDEF861E5Q35938040-65761372-5945-4C0F-B8D8-CD3B1ED48DFAQ36199767-3E1D5389-673C-46AC-9FDC-2E980EC95BE5Q36303477-DA548DB0-3265-4D27-9448-619136CC5620Q36514695-8E301EED-E896-4662-86C7-ED41BCCE3E97Q36778814-4C5E44DB-175D-471D-A8C1-94B60A617EAAQ36960966-D64DB45D-E3E7-46F8-8A7A-78759BEEC9B1Q37346684-58D9F286-263C-4E51-809C-0A14DFDF18D7Q37571181-B6AB3D8A-54A4-4E9B-8C2D-A47638916350Q37709524-8FC11694-A697-40F7-86A8-7DB43CC1739AQ38325566-3F9B2127-A841-44B1-B7BE-59040D059F15Q38328333-F54FD4C0-7622-4BAE-A9F2-E1769EE2C51EQ38366661-FBC50ED5-AB4B-4429-B01C-394E649A4620Q38388349-4ABD6079-234C-4AAB-9BDE-F92267AB8FCFQ38419194-C1D5D5B1-5F17-48E6-B9ED-ACF90F6F2C4DQ38424483-3399EA10-C043-4272-8B00-DAA7412C9FDFQ38573631-747B4E35-E107-4F24-A198-B2E643138D6AQ38753216-95A0F99F-AEC9-4FE8-BCA8-D2B5EE4C9542Q38908764-1407BDCA-9405-4654-B40F-805AB09F1365Q38921406-903B32B3-A59D-4A97-850D-C17E7A8E554DQ38957840-1BA23443-B11D-4B21-96AC-38781133A6A0Q39319145-0C2861E1-A8C0-439D-A001-5D1B9528BB30Q40312760-7EC2C838-B8A0-42BE-9E7A-02CDFE95DC01Q40767311-B0957318-6544-4904-A908-8E1BDCE03E9FQ40816924-5FB254A7-BEE6-4E43-AA18-8DF7AF7E0F4DQ41701253-511DD10B-A3F8-420A-974D-27C51085A8EBQ43058864-72D46DDC-3E1E-418F-9485-7A7D154ED192Q43651454-85206D28-39C2-4553-A24C-12439AC362BE
P2860
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@ast
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@en
type
label
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@ast
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@en
prefLabel
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@ast
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@en
P2093
P2860
P356
P1476
Biliary repair and carcinogene ...... t cholangiocyte proliferation.
@en
P2093
Jorge A Bezerra
Kazuhiko Bessho
Nataliya Razumilava
Pranavkumar Shivakumar
Reena Mourya
Shannon S Glaser
Stephanie Walters
Tatsuki Mizuochi
Yui-Hsi Wang
P2860
P304
P356
10.1172/JCI73742
P407
P577
2014-06-02T00:00:00Z